Highlights CareDx, Inc

Equities

CDNA

US14167L1035

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-22 pm EDT			5-day change	1st Jan Change
15.57 ^USD	+2.91%		+5.35%	+29.75%

May. 17	Craig-Hallum Adjusts Price Target on CareDx to $22 From $15, Maintains Buy Rating	MT
May. 16	Study Shows CareDx, Inc.?s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Study Shows CareDx, Inc.?s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies	May. 16	CI
Sector Update: Health Care Stocks Higher Late Afternoon	May. 10	MT
CareDx Shares Rise After Q1 Results Beat Estimates	May. 10	MT
Earnings Flash (CDNA) CAREDX Reports Q1 Revenue $72M, vs. Street Est of $63.1M	May. 09	MT
CareDx, Inc Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
Earnings Flash (CDNA) CAREDX Reports Q4 Revenue $65.6M, vs. Street Est of $64.1M	Feb. 28	MT
CareDx, Inc Provides Revenue Guidance for the Full Year of 2024	Feb. 28	CI
CareDx, Inc Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 28	CI
CareDx, Inc Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring	Feb. 21	CI
Natera Awarded About $96.3 Million in Patent Infringement Case Against CareDx	Jan. 29	MT
CareDx's Preliminary Q4, 2023 Revenue Top Consensus	Jan. 09	MT
Tranche Update on CareDx, Inc's Equity Buyback Plan announced on December 6, 2022.	Jan. 09	CI
CareDx, Inc Provides Earnings Guidance for Fourth Quarter Ended December 31, 2023	Jan. 09	CI
CareDx, Inc Revises Revenue Guidance for the Full Year Ended December 31, 2023	Jan. 09	CI
Natera Says Delaware Court Denies CareDx's Motion for Summary Judgment on Two Patents, Lawsuit to Proceed to Trial	Dec. 11	MT
Natera Says Delaware Court Denies CareDx's Motion for Summary Judgment on Two Patents, Lawsuit to Proceed to Trial	Dec. 11	MT
CareDx Surges 14% Premarket Thursday After Reporting Q3 Revenue Above Expectations, Lifting Full-Year Sales Guidance	Nov. 09	MT
Tranche Update on CareDx, Inc's Equity Buyback Plan announced on December 6, 2022.	Nov. 08	CI
CareDx, Inc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI
Earnings Flash (CDNA) CAREDX Reports Q3 Revenue $67.2M, vs. Street Est of $53.1M	Nov. 08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights CareDx, Inc

Equities

CDNA

US14167L1035

Highlights

Filters